• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Understanding the Role of Neuropsychiatric Symptoms in Functional Decline in Alzheimer's Disease.了解神经精神症状在阿尔茨海默病功能衰退中的作用。
J Neuropsychiatry Clin Neurosci. 2025 Jun 26:appineuropsych20250015. doi: 10.1176/appi.neuropsych.20250015.
2
Pharmacological interventions for apathy in Alzheimer's disease.阿尔茨海默病中淡漠症状的药物干预措施。
Cochrane Database Syst Rev. 2018 May 4;5(5):CD012197. doi: 10.1002/14651858.CD012197.pub2.
3
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
4
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
5
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
6
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
7
Selegiline for Alzheimer's disease.司来吉兰用于治疗阿尔茨海默病。
Cochrane Database Syst Rev. 2003(1):CD000442. doi: 10.1002/14651858.CD000442.
8
Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.尼麦角林治疗痴呆及其他与年龄相关的认知障碍形式的疗效。
Cochrane Database Syst Rev. 2001;2001(4):CD003159. doi: 10.1002/14651858.CD003159.
9
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.痴呆症老年人行为和心理症状的慢性抗精神病药物撤药与继续用药对比
Cochrane Database Syst Rev. 2013 Mar 28(3):CD007726. doi: 10.1002/14651858.CD007726.pub2.
10
Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.在痴呆症患者中,停用或继续使用胆碱酯酶抑制剂、美金刚或两者。
Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.

本文引用的文献

1
Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline.阿尔茨海默病的神经精神症状特征及其与功能衰退的关系。
Am J Geriatr Psychiatry. 2024 Dec;32(12):1402-1416. doi: 10.1016/j.jagp.2024.06.005. Epub 2024 Jun 29.
2
Specific mechanisms underlying executive and emotional apathy: A phenotyping study.执行和情感冷漠的具体机制:表型研究。
J Psychiatr Res. 2024 Apr;172:35-46. doi: 10.1016/j.jpsychires.2024.02.022. Epub 2024 Feb 8.
3
Neuropsychiatric Symptom Burden across Neurodegenerative Disorders and its Association with Function.神经退行性疾病的神经精神症状负担及其与功能的关系。
Can J Psychiatry. 2023 May;68(5):347-358. doi: 10.1177/07067437221147443. Epub 2023 Jan 13.
4
Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline.认知正常的老年人群中淡漠、焦虑和抑郁的发展:阿尔茨海默病病理和认知衰退的影响。
Biol Psychiatry. 2022 Jul 1;92(1):34-43. doi: 10.1016/j.biopsych.2022.01.012. Epub 2022 Jan 31.
5
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias.神经精神症状与阿尔茨海默病及相关痴呆的神经病理学诊断之间的关联。
JAMA Psychiatry. 2022 Apr 1;79(4):359-367. doi: 10.1001/jamapsychiatry.2021.4363.
6
Clinical Trajectories of Neuropsychiatric Symptoms in Mild-Moderate to Advanced Dementia.轻度-中度至晚期痴呆患者神经精神症状的临床轨迹。
J Alzheimers Dis. 2022;86(2):861-875. doi: 10.3233/JAD-215133.
7
Diagnostic criteria for apathy in neurocognitive disorders.神经认知障碍中淡漠的诊断标准。
Alzheimers Dement. 2021 Dec;17(12):1892-1904. doi: 10.1002/alz.12358. Epub 2021 May 5.
8
Neuropsychiatric symptoms and the outcome of cognitive trajectories in older adults free of dementia: The Mayo Clinic Study of Aging.无认知障碍的老年人的神经精神症状与认知轨迹的结果:梅奥诊所老龄化研究。
Int J Geriatr Psychiatry. 2021 Sep;36(9):1362-1369. doi: 10.1002/gps.5528. Epub 2021 Mar 24.
9
Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials.阿尔茨海默病临床试验临床结局评估中的疾病严重程度及最小临床重要差异
Alzheimers Dement (N Y). 2019 Aug 2;5:354-363. doi: 10.1016/j.trci.2019.06.005. eCollection 2019.
10
Neuropsychiatric Symptoms as Predictors of Clinical Course in Neurodegeneration. A Longitudinal Study.神经精神症状作为神经退行性疾病临床病程的预测指标。一项纵向研究。
Front Aging Neurosci. 2019 Jul 24;11:176. doi: 10.3389/fnagi.2019.00176. eCollection 2019.

了解神经精神症状在阿尔茨海默病功能衰退中的作用。

Understanding the Role of Neuropsychiatric Symptoms in Functional Decline in Alzheimer's Disease.

作者信息

Zhu Carolyn W, Schneider Lon S, Soleimani Laili, Neugroschl Judith, Grossman Hillel T, Schimming Corbett, Sano Mary

机构信息

Brookdale Department of Geriatrics and Palliative Medicine (Zhu) and Alzheimer's Disease Research Center, Department of Psychiatry (Zhu, Soleimani, Neugroschl, Grossman, Schimming, Sano), Icahn School of Medicine at Mount Sinai, New York City; James J. Peters Department of Veterans Affairs Medical Center, New York City (Grossman, Schimming, Sano); Department of Psychiatry, Neurology, and Gerontology, Keck School of Medicine and Leonard Davis School of Gerontology, University of Southern California, Los Angeles (Schneider).

出版信息

J Neuropsychiatry Clin Neurosci. 2025 Jun 26:appineuropsych20250015. doi: 10.1176/appi.neuropsych.20250015.

DOI:10.1176/appi.neuropsych.20250015
PMID:40566859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12320021/
Abstract

OBJECTIVE

The authors explored classes of neuropsychiatric symptoms (NPSs) in Alzheimer's disease (AD), examined the relationship between NPS classes on rate of functional decline over time, and determined whether effects of individual symptoms on functional decline remained after controlling for NPS classes.

METHODS

The authors longitudinally analyzed 9,797 study participants with mild cognitive impairment or AD at baseline in the National Alzheimer's Coordinating Center Uniform Data Set. Function was measured with the Functional Assessment Questionnaire, and NPSs were assessed by using clinician judgment. Latent class analysis (LCA) was used to identify clusters of individuals who shared similar NPS profiles. Linear mixed models were used to estimate the relationship between NPS classes and individual symptom profiles in functional decline over time.

RESULTS

LCA revealed four distinct NPS classes: an asymptomatic-mild group (48.2% of the sample, N=4,721), a second group predominantly having apathy and depression (36.4%, N=3,562), a third group with high rates of multiple symptoms except for hallucinations (12.8%, N=1,250), and a small group with high rates of all symptoms (complex class, 2.7%, N=264). NPS classes differed in baseline function but were not significantly associated with rate of functional decline. When NPS classes were controlled for, persistent apathy remained strongly associated with a faster rate of functional decline. Effects of apathy were observed across NPS classes and disease severity levels.

CONCLUSIONS

Specific symptoms rather than classes of symptoms were associated with the trajectory of functional decline in AD. Apathy may be particularly useful for tracking longitudinal changes in function.

摘要

目的

作者探究了阿尔茨海默病(AD)中的神经精神症状(NPSs)类别,研究了NPS类别与功能随时间下降速率之间的关系,并确定在控制NPS类别后,个体症状对功能下降的影响是否依然存在。

方法

作者对国家阿尔茨海默病协调中心统一数据集中9797名基线时患有轻度认知障碍或AD的研究参与者进行了纵向分析。功能通过功能评估问卷进行测量,NPSs由临床医生判断评估。潜在类别分析(LCA)用于识别具有相似NPS特征的个体集群。线性混合模型用于估计NPS类别与功能随时间下降过程中个体症状特征之间的关系。

结果

LCA揭示了四个不同的NPS类别:无症状 - 轻度组(占样本的48.2%,N = 4721),第二组主要表现为淡漠和抑郁(36.4%,N = 3562),第三组除幻觉外多种症状发生率高(12.8%,N = 1250),以及一小组所有症状发生率高的复杂类别(2.7%,N = 264)。NPS类别在基线功能方面存在差异,但与功能下降速率无显著关联。在控制NPS类别后,持续性淡漠仍与更快的功能下降速率密切相关。在所有NPS类别和疾病严重程度水平上均观察到淡漠的影响。

结论

在AD中,与功能下降轨迹相关的是特定症状而非症状类别。淡漠可能对追踪功能的纵向变化特别有用。